Advertisement

Aggregation-Induced Emission Luminogens for Biomedical Applications

  • Dan Ding
Chapter

Abstract

In recent years, luminogens with aggregation-induced emission (AIE) feature have attracted a great deal of attention, and been used in many high-tech fields. One important application is the biological diagnostics and therapeutics. Thus far, AIE luminogens (AIEgens) have been successfully utilized for in vitro/in vivo imaging and therapy, which show excellent performance and great promise. AIEgens have several notable characteristics, such as high brightness, large Stokes shift, marked photostability, and good biocompatibility, making them very suitable for biomedical applications. In this chapter, the recent development of AIEgens as biological agents is summarized, including the in vivo imaging with AIE nanoparticles, activable probes with special turn-on signature, near-infrared AIEgens for high-resolution imaging, theranostic systems combining diagnostic with therapeutic capabilities, and emerging multi-modality platforms. The future perspectives of AIEgens for biomedical applications are also discussed in this chapter.

Keywords

Aggregation-induced emission Biomedical application Nanoparticle Activable probe Near-infrared Theranostics Multi-modality 

Notes

Acknowledgment

The authors gratefully acknowledge financial support provided by the National Natural Science Foundation of China (51622305).

References

  1. 1.
    Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7(7):591–607CrossRefGoogle Scholar
  2. 2.
    Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452(187):580–589CrossRefGoogle Scholar
  3. 3.
    Antonsen SL et al (2013) MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol 128(2):300–308CrossRefGoogle Scholar
  4. 4.
    Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7(5):626–634CrossRefGoogle Scholar
  5. 5.
    Lee MH, Kim JS, Sessler JL (2015) Small molecule-based ratiometric fluorescence probes for cations, anions, and biomolecules. Chem Soc Rev 44(13):4185–4191CrossRefGoogle Scholar
  6. 6.
    Michalet X et al (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709):538–544CrossRefGoogle Scholar
  7. 7.
    Wu C, Bull B, Szymanski C, Christensen K, McNeill J (2018) Multicolor conjugated polymer dots for biological fluorescence imaging. ACS Nano 2(11):2415–2423CrossRefGoogle Scholar
  8. 8.
    Boens N, Leen V, Dehaen W (2012) Fluorescent indicators based on BODIPY. Chem Soc Rev 41(3):1130–1172CrossRefGoogle Scholar
  9. 9.
    Pansare VJ, Hejazi S, Faenza WJ, Prud’homme RK (2012) Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores, and multifunctional nano carriers. Chem Mater 24(5):812–827CrossRefGoogle Scholar
  10. 10.
    Feng G et al (2014) Ultrabright organic dots with aggregation-induced emission characteristics for cell tracking. Biomaterials 35(30):8669–8677CrossRefGoogle Scholar
  11. 11.
    Oushiki D et al (2010) Development and application of a near-infrared fluorescence probe for oxidative stress based on differential reactivity of linked cyanine dyes. J Am Chem Soc 132(8):2795–2801CrossRefGoogle Scholar
  12. 12.
    Hong Y, Lam JWY, Tang BZ (2009) Aggregation-induced emission: phenomenon, mechanism and applications. Chem Commun (29):4332–4353Google Scholar
  13. 13.
    Luo J et al (2001) Aggregation-induced emission of 1-methyl-1,2,3,4,5-pentaphenylsilole. Chem Commun (18):1740–1741Google Scholar
  14. 14.
    Hong Y, Lam JWY, Tang BZ (2011) Aggregation-induced emission. Chem Soc Rev 40(11):5361–5388CrossRefGoogle Scholar
  15. 15.
    Mei J, Leung NLC, Kwok RTK, Lam JWY, Tang BZ (2015) Aggregation-induced emission: together we shine, united we soar! Chem Rev 115(21):11718–11940CrossRefGoogle Scholar
  16. 16.
    Zhao Z, Lam JWY, Tang BZ (2012) Tetraphenylethene: a versatile AIE building block for the construction of efficient luminescent materials for organic light-emitting diodes. J Mater Chem 22(45):23726–23740CrossRefGoogle Scholar
  17. 17.
    Hu R et al (2009) Twisted intramolecular charge transfer and aggregation-induced emission of BODIPY derivatives. J Phys Chem C 113(36):15845–15853CrossRefGoogle Scholar
  18. 18.
    Zhang H et al (2017) Why do simple molecules with “isolated” phenyl rings emit visible light? J Am Chem Soc 139(45):16264–16272CrossRefGoogle Scholar
  19. 19.
    Wang D et al (2017) Facile synthesis of red/NIR AIE luminogens with simple structures, bright emissions, and high photostabilities, and their applications for specific imaging of lipid droplets and image-guided photodynamic therapy. Adv Funct Mater 27(46):1704039CrossRefGoogle Scholar
  20. 20.
    Du X, Qi J, Zhang Z, Ma D, Wang ZY (2012) Efficient non-doped near infrared organic light-emitting devices based on fluorophores with aggregation-induced emission enhancement. Chem Mater 24(11):2178–2185CrossRefGoogle Scholar
  21. 21.
    Ding D, Li K, Liu B, Tang BZ (2013) Bioprobes based on AIE fluorogens. Acc Chem Res 46(11):2441–2453CrossRefGoogle Scholar
  22. 22.
    Ding D et al (2015) A fluorescent light-up nanoparticle probe with aggregation-induced emission characteristics and tumor-acidity responsiveness for targeted imaging and selective suppression of cancer cells. Mater Horiz 2(1):100–105CrossRefGoogle Scholar
  23. 23.
    Qian J, Tang BZ (2017) AIE luminogens for bioimaging and theranostics: from organelles to animals. Chem 3(4):56–91CrossRefGoogle Scholar
  24. 24.
    Yi X et al (2017) In vivo cancer research using aggregation-induced emission organic nanoparticles. Drug Discov Today 22(9):1412–1420CrossRefGoogle Scholar
  25. 25.
    Qin W et al (2012) Biocompatible nanoparticles with aggregation-induced emission characteristics as far-red/near-infrared fluorescent bioprobes for in vitro and in vivo imaging applications. Adv Funct Mater 22(4):771–779CrossRefGoogle Scholar
  26. 26.
    Li D, Qin W, Xu B, Qian J, Tang BZ (2017) AIE nanoparticles with high stimulated emission depletion efficiency and photobleaching resistance for long-term super-resolution bioimaging. Adv Mater 29(43):1703643CrossRefGoogle Scholar
  27. 27.
    Wang Y et al (2015) Smart albumin-biomineralized nanocomposites for multimodal imaging and photothermal tumor ablation. Adv Mater 27(26):3874–3882CrossRefGoogle Scholar
  28. 28.
    Park S et al (2015) Amphiphilized poly(ethyleneimine) nanoparticles: a versatile multi-cargo carrier with enhanced tumor-homing efficiency and biocompatibility. J Mater Chem B 3(2):198–206CrossRefGoogle Scholar
  29. 29.
    Maeda H (2015) Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev 91:3–6CrossRefGoogle Scholar
  30. 30.
    Ly HQ, Frangioni JV, Hajjar RJ (2008) Imaging in cardiac cell-based therapy: in vivo tracking of the biological fate of therapeutic cells. Nat Clin Pract Cardiovasc Med 5:S96–S102CrossRefGoogle Scholar
  31. 31.
    Doubrovin MM et al (2007) In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res 67(24):11959–11969CrossRefGoogle Scholar
  32. 32.
    Li K et al (2013) Photostable fluorescent organic dots with aggregation-induced emission (AIE dots) for noninvasive long-term cell tracing. Sci Rep 3:1150CrossRefGoogle Scholar
  33. 33.
    Ding D et al (2014) Precise and long-term tracking of adipose-derived stem cells and their regenerative capacity via superb bright and stable organic nanodots. ACS Nano 8(12):12620–12631CrossRefGoogle Scholar
  34. 34.
    Larson DR et al (2003) Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300(5624):1434–1436CrossRefGoogle Scholar
  35. 35.
    He GS, Tan LS, Zheng Q, Prasad PN (2008) Multiphoton absorbing materials: molecular designs, characterizations, and applications. Chem Rev 108(4):1245–1330CrossRefGoogle Scholar
  36. 36.
    Qian J et al (2015) High-order non-linear optical effects in organic luminogens with aggregation-induced emission. Adv Mater 27(14):2332–2339CrossRefGoogle Scholar
  37. 37.
    Wang D et al (2014) Biocompatible and photostable AIE dots with red emission for in vivo two-photon bioimaging. Sci Rep 4:4279CrossRefGoogle Scholar
  38. 38.
    Lou X, Zhao Z, Tang BZ (2016) Organic dots based on AIEgens for two-photon fluorescence bioimaging. Small 12(47):6430–6450CrossRefGoogle Scholar
  39. 39.
    Ding D et al (2013) Ultrabright organic dots with aggregation-induced emission characteristics for real-time two-photon intravital vasculature imaging. Adv Mater 25(42):6083–6088CrossRefGoogle Scholar
  40. 40.
    Yuan Y, Kwok RTK, Tang BZ, Liu B (2014) Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. J Am Chem Soc 136(6):2546–2554CrossRefGoogle Scholar
  41. 41.
    Han A et al (2016) Peptide-induced AIEgen self-assembly: a new strategy to realize highly sensitive fluorescent light-up probes. Anal Chem 88(7):3872–3878CrossRefGoogle Scholar
  42. 42.
    Kobayashi H, Choyke PL (2011) Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. Acc Chem Res 44(2):83–90CrossRefGoogle Scholar
  43. 43.
    Wang J et al (2011) Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res 71(23):7238–7249CrossRefGoogle Scholar
  44. 44.
    Ding D et al (2014) Light-up bioprobe with aggregation-induced emission characteristics for real-time apoptosis imaging in target cancer cells. J Mater Chem B 2(2):231–238CrossRefGoogle Scholar
  45. 45.
    Yuan Y, Xu S, Cheng X, Cai X, Liu B (2016) Bioorthogonal turn-on probe based on aggregation-induced emission characteristics for cancer cell imaging and ablation. Angew Chem Int Ed 55(22):6457–6461CrossRefGoogle Scholar
  46. 46.
    Yuan Y, Liu B (2017) Visualization of drug delivery processes using AIEgens. Chem Sci 8(4):2537–2546CrossRefGoogle Scholar
  47. 47.
    Qian G, Wang ZY (2010) Near-infrared organic compounds and emerging applications. Chem Asian J 5(5):1006–1029CrossRefGoogle Scholar
  48. 48.
    Han X et al (2015) Highly efficient solid-state near-infrared emitting material based on triphenylamine and diphenylfumaronitrile with an EQE of 2.58% in nondoped organic light-emitting diode. Adv Funct Mater 25(48):7521–7529CrossRefGoogle Scholar
  49. 49.
    Chen G et al (2015) Nanostructure formation-induced fluorescence turn-on for selectively detecting protein thiols in solutions, bacteria and live cells. Chem Commun 51(53):10758–10761CrossRefGoogle Scholar
  50. 50.
    Ow SY, Dunstan DE (2014) A brief overview of amyloids and Alzheimer’s disease. Protein Sci 23(10):1315–1331CrossRefGoogle Scholar
  51. 51.
    Wang H et al (2014) Self-assembly-induced far-red/near-infrared fluorescence light-up for detecting and visualizing specific protein-peptide interactions. ACS Nano 8(2):1475–1484CrossRefGoogle Scholar
  52. 52.
    Raj L et al (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475(7355):231–234CrossRefGoogle Scholar
  53. 53.
    Pu K, Shuhendler AJ, Rao J (2013) Semiconducting polymer nanoprobe for in vivo imaging of reactive oxygen and nitrogen species. Angew Chem Int Ed 52(39):10325–10329CrossRefGoogle Scholar
  54. 54.
    Zhang J et al (2017) Activatable photoacoustic nanoprobes for in vivo ratiometric imaging of peroxynitrite. Adv Mater 29(6):1604764CrossRefGoogle Scholar
  55. 55.
    Yin C et al (2017) Organic nanoprobe cocktails for multilocal and multicolor fluorescence imaging of reactive oxygen species. Adv Funct Mater 27(23):1700493CrossRefGoogle Scholar
  56. 56.
    Song Z et al (2016) Activatable fluorescent nanoprobe with aggregation-induced emission characteristics for selective in vivo imaging of elevated peroxynitrite generation. Adv Mater 28(33):7249–7256CrossRefGoogle Scholar
  57. 57.
    Hong G, Antaris AL, Dai H (2017) Near-infrared fluorophores for biomedical imaging. Nat Biomed Eng 1:0010CrossRefGoogle Scholar
  58. 58.
    Hemmer E, Benayas A, Légaré F, Vetrone F (2016) Exploiting the biological windows: current perspectives on fluorescent bioprobes emitting above 1000 nm. Nanoscale Horiz 1(3):168–184CrossRefGoogle Scholar
  59. 59.
    Antaris AL et al (2016) A small-molecule dye for NIR-II imaging. Nat Mater 15(2):235–242CrossRefGoogle Scholar
  60. 60.
    Qi J, Qiao W, Wang ZY (2016) Advances in organic near-infrared materials and emerging applications. Chem Rec 16(3):1531–1548CrossRefGoogle Scholar
  61. 61.
    Qi J et al (2014) Panchromatic small molecules for UV-Vis-NIR photodetectors with high detectivity. J Mater Chem C 2(13):2431–2438CrossRefGoogle Scholar
  62. 62.
    Nguyen QT, Tsien RY (2013) Fluorescence-guided surgery with live molecular navigation-a new cutting edge. Nat Rev Cancer 13(9):653–662CrossRefGoogle Scholar
  63. 63.
    Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJH, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10(9):507–518CrossRefGoogle Scholar
  64. 64.
    Liu J et al (2017) Long wavelength excitable near-infrared fluorescent nanoparticles with aggregation-induced emission characteristics for image-guided tumor resection. Chem Sci 8(4):2782–2789CrossRefGoogle Scholar
  65. 65.
    Yang Q et al (2017) Rational design of molecular fluorophores for biological imaging in the NIR-II window. Adv Mater 29(12):1605497CrossRefGoogle Scholar
  66. 66.
    Sun Y et al (2016) Novel benzo-bis(1,2,5-thiadiazole) fluorophores for in vivo NIR-II imaging of cancer. Chem Sci 7(9):6203CrossRefGoogle Scholar
  67. 67.
    Qi J et al (2018) Real-time and high-resolution bioimaging with bright aggregation-induced emission dots in short-wave infrared region. Adv Mater 30(12):e1706856.  https://doi.org/10.1002/adma.1706856CrossRefGoogle Scholar
  68. 68.
    Jokerst JV, Gambhir SS (2011) Molecular imaging with theranostic nanoparticles. Acc Chem Res 44(10):1050–1060CrossRefGoogle Scholar
  69. 69.
    Xie J, Lee S, Chen X (2010) Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62(11):1064–1079CrossRefGoogle Scholar
  70. 70.
    Lovell JF, Liu TWB, Chen J, Zheng G (2010) Activatable photosensitizers for imaging and therapy. Chem Rev 110(5):2839–2857CrossRefGoogle Scholar
  71. 71.
    Hu F et al (2014) Targeted bioimaging and photodynamic therapy of cancer cells with an activatable red fluorescent bioprobe. Anal Chem 86(15):7987–7995CrossRefGoogle Scholar
  72. 72.
    Zhang CZ et al (2015) Image-guided combination chemotherapy and photodynamic therapy using a mitochondria-targeted molecular probe with aggregation-induced emission characteristics. Chem Sci 6(8):4580–4586CrossRefGoogle Scholar
  73. 73.
    Wu W et al (2017) A highly efficient and photostable photosensitizer with near-infrared aggregation-induced emission for image-guided photodynamic anticancer therapy. Adv Mater 29(33):1700548CrossRefGoogle Scholar
  74. 74.
    Chen C et al (2017) AIEgen-based theranostic system: targeted imaging of cancer cells and adjuvant amplification of antitumor efficacy of paclitaxel. Chem Sci 8(3):2191–2198CrossRefGoogle Scholar
  75. 75.
    Adams SR et al (2016) Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize. Nat Commun 7:13019CrossRefGoogle Scholar
  76. 76.
    Eckardt A, Sinikovic B, Hofele C, Bremer M, Reuter C (2007) Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial. Oncology 73(3–4):198–203CrossRefGoogle Scholar
  77. 77.
    Yu CYY et al (2017) Mitochondrion-anchoring photosensitizer with aggregation-induced emission characteristics synergistically boosts the radiosensitivity of cancer cells to ionizing radiation. Adv Mater 29(15):1606167CrossRefGoogle Scholar
  78. 78.
    Lovell JF et al (2011) Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 10(4):324–332CrossRefGoogle Scholar
  79. 79.
    Cheng L et al (2014) PEGylated WS2 nanosheets as a multifunctional theranostic agent for in vivo dual-modal CT/photoacoustic imaging guided photothermal therapy. Adv Mater 26(12):1886–1893CrossRefGoogle Scholar
  80. 80.
    Huynh E et al (2015) In situ conversion of porphyrin microbubbles to nanoparticles for multimodality imaging. Nat Nanotechnol 10(4):325–332CrossRefGoogle Scholar
  81. 81.
    Zhang J et al (2015) In vivo tumor-targeted dual-modal fluorescence/CT imaging using a nanoprobe co-loaded with an aggregation-induced emission dye and gold nanoparticles. Biomaterials 42:103–111CrossRefGoogle Scholar
  82. 82.
    Wang LV, Hu S (2012) Photoacoustic tomography: in vivo imaging from organelles to organs. Science 335(6075):1458–1462CrossRefGoogle Scholar
  83. 83.
    Zhang HF, Maslov K, Stoica G, Wang LV (2006) Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat Biotechnol 24(7):848–851CrossRefGoogle Scholar
  84. 84.
    Li K, Liu B (2014) Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging. Chem Soc Rev 43(18):6570–6597CrossRefGoogle Scholar
  85. 85.
    Feng G, Liu B (2016) Multifunctional AIEgens for future theranostics. Small 12(47):6528–6535CrossRefGoogle Scholar
  86. 86.
    Qi J et al (2017) Highly stable organic small molecular nanoparticles as an advanced and biocompatible phototheranostic agent of tumor in living mice. ACS Nano 11(7):7177–7188CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, and College of Life SciencesNankai UniversityTianjinChina

Personalised recommendations